Articles by Jennifer G. Robinson (7)

Another treatment gap: Restarting secondary prevention medications: The Women's Health Initiative

Jennifer G. Robinson, Robert Wallace, Monika M. Safford, Mary Pettinger, Barbara Cochrane and Marcia G. Ko

Journal of Clinical Lipidology 4 ( 1 ): 36 - 45 , 2010

Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006

Jennifer G. Robinson and Benjamin Booth

Journal of Clinical Lipidology 4 ( 6 ): 483 - 490 , 2010

In search of self-awareness: Results of the National Lipid Association 2010 Lipid Pulse Membership Survey

Carl E. Orringer, Jennifer G. Robinson, Ralph La Forge and Christopher R. Seymour

Journal of Clinical Lipidology 5 ( 1 ): 12 - 17 , 2011

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Anne C. Goldberg, Paul N. Hopkins, Peter P. Toth, Christie M. Ballantyne, Daniel J. Rader, Jennifer G. Robinson, Stephen R. Daniels, Samuel S. Gidding, Sarah D. de Ferranti, Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty, William C. Cromwell, Joyce L. Ross and Paul E. Ziajka

Journal of Clinical Lipidology 5 ( 3 ): 133 - 140 , 2011

Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men

Jennifer G. Robinson, Catherine Rahilly-Tierney, Elizabeth Lawler and J. Michael Gaziano

Journal of Clinical Lipidology 6 ( 1 ): 58 - 65 , 2012

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome

Jennifer G. Robinson, Christie M. Ballantyne, Willa A. Hsueh, Jeffrey B. Rosen, Jianxin Lin, Arvind K. Shah, Joanne E. Tomassini, Robert S. Lowe and Andrew M. Tershakovec

Journal of Clinical Lipidology 7 ( 4 ): 292 - 303 , 2013

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

Jennifer G. Robinson, Christie M. Ballantyne, Willa Hsueh, Jeffrey Rosen, Jianxin Lin, Arvind Shah, Robert S. Lowe, Mary E. Hanson and Andrew M. Tershakovec

Journal of Clinical Lipidology 5 ( 6 ): 474 - 482 , 2011

Do you have a suggestion for journals

Suggest Journal